Announced Fri, 8 May · 19:01 IST

Please Find Enclosed herewith Resignation of Mr. Arun Dash as Non - Executive Independent Director

Multiple Ind Directors ResignedDirector Flagged GovernanceManagement Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.9%1-day move
₹283.00
prior close
₹250.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0-2.9-7.8-3.9-8.1-7.1-9.2-8.4
Up moveDown movePending
AI summary

Accretion Nutraveda Ltd's board meeting on May 8, 2026 approved audited FY2026 results showing strong growth: total income rose to ₹3,371.55 Lakhs (up 111% from ₹1,600.80 Lakhs) and net profit after tax reached ₹506.83 Lakhs (up 103% from ₹250.09 Lakhs). Two Non-Executive Independent Directors resigned - Mr. Arun Dash citing personal commitments and Mr. Mahipal Singh Chouhan citing increased professional engagements. Both confirmed no material reasons for their departure. To fill the vacancies, the board appointed Mr. Chand Rameshbhai Kanabar and Ms. Grishma A Shewale as Additional Independent Directors for a 5-year term each, subject to shareholder approval. The company also reappointed Sakhiya & Co. as secretarial auditors and appointed U M T & Co. as internal auditors for FY 2026-27.

Likely market impact

The resignation of two independent directors on the same day raises governance concerns, though the company has promptly appointed replacements. The strong financial performance (EPS ₹9.35 vs ₹6.88) and recent IPO listing on BSE SME platform (February 2026) provide a positive backdrop, but investors should monitor the board composition and any committee functioning issues.